Polymyalgia Rheumatica could be safely, effectively treated with tofacitinib, avoiding the need for steroids, per new proof-of-concept Randomized Controlled Trial
#####
In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine : http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004249
Article Title: Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): An open-label randomized controlled trial
Author Countries : China
Funding: This work was supported by Natural Science Foundation of China (82171768 to WQC), National Key Research and Development Program of China (2022YFC3602000 to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
PLOS Medicine
Randomized controlled/clinical trial
People
Competing interests: The authors have declared that no competing interests exist.